IL101056A - Composition for nasal treatment - Google Patents

Composition for nasal treatment

Info

Publication number
IL101056A
IL101056A IL101056A IL10105692A IL101056A IL 101056 A IL101056 A IL 101056A IL 101056 A IL101056 A IL 101056A IL 10105692 A IL10105692 A IL 10105692A IL 101056 A IL101056 A IL 101056A
Authority
IL
Israel
Prior art keywords
composition
alleviation
molecular weight
concentration
nasal
Prior art date
Application number
IL101056A
Other languages
English (en)
Other versions
IL101056A0 (en
Original Assignee
Res & Dev Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IL101056A priority Critical patent/IL101056A/xx
Application filed by Res & Dev Co Ltd filed Critical Res & Dev Co Ltd
Publication of IL101056A0 publication Critical patent/IL101056A0/xx
Priority to GB9301938A priority patent/GB2264235B/en
Priority to NL9300263A priority patent/NL9300263A/nl
Priority to FI930656A priority patent/FI930656A/fi
Priority to CH456/93A priority patent/CH685099A5/de
Priority to BE9300146A priority patent/BE1006233A3/fr
Priority to DE4304893A priority patent/DE4304893A1/de
Priority to US08/019,435 priority patent/US5376365A/en
Priority to SE9300581A priority patent/SE9300581L/
Priority to AU33756/93A priority patent/AU669351B2/en
Priority to DK019893A priority patent/DK19893A/da
Priority to FR9302036A priority patent/FR2687573B1/fr
Priority to CA002090749A priority patent/CA2090749A1/en
Publication of IL101056A publication Critical patent/IL101056A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL101056A 1992-02-24 1992-02-24 Composition for nasal treatment IL101056A (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IL101056A IL101056A (en) 1992-02-24 1992-02-24 Composition for nasal treatment
GB9301938A GB2264235B (en) 1992-02-24 1993-02-01 Composition for nasal treatment
NL9300263A NL9300263A (nl) 1992-02-24 1993-02-10 Farmaceutische samenstelling voor intranasale toepassing voor de behandeling en verlichting van nasale ongemakken en ziekten en voor verlichting van "droge neus-syndroom"
FI930656A FI930656A (fi) 1992-02-24 1993-02-15 Komposition foer nasal behandling
CH456/93A CH685099A5 (de) 1992-02-24 1993-02-15 Pharmazeutisches Präparat für die intranasale Anwendung.
BE9300146A BE1006233A3 (fr) 1992-02-24 1993-02-16 Composition pour application nasale.
DE4304893A DE4304893A1 (da) 1992-02-24 1993-02-17
US08/019,435 US5376365A (en) 1992-02-24 1993-02-18 Method of the treatment of dry nose syndrome
SE9300581A SE9300581L (sv) 1992-02-24 1993-02-22 Komposition för nasalbehandling
AU33756/93A AU669351B2 (en) 1992-02-24 1993-02-23 Method of the treatment of dry nose syndrome
DK019893A DK19893A (da) 1992-02-24 1993-02-23 Praeparat til nasal behandling
FR9302036A FR2687573B1 (fr) 1992-02-24 1993-02-23 Composition pour application nasale.
CA002090749A CA2090749A1 (en) 1992-02-24 1993-02-24 Composition for nasal treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL101056A IL101056A (en) 1992-02-24 1992-02-24 Composition for nasal treatment

Publications (2)

Publication Number Publication Date
IL101056A0 IL101056A0 (en) 1992-11-15
IL101056A true IL101056A (en) 1997-03-18

Family

ID=11063390

Family Applications (1)

Application Number Title Priority Date Filing Date
IL101056A IL101056A (en) 1992-02-24 1992-02-24 Composition for nasal treatment

Country Status (13)

Country Link
US (1) US5376365A (da)
AU (1) AU669351B2 (da)
BE (1) BE1006233A3 (da)
CA (1) CA2090749A1 (da)
CH (1) CH685099A5 (da)
DE (1) DE4304893A1 (da)
DK (1) DK19893A (da)
FI (1) FI930656A (da)
FR (1) FR2687573B1 (da)
GB (1) GB2264235B (da)
IL (1) IL101056A (da)
NL (1) NL9300263A (da)
SE (1) SE9300581L (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
DE10064219B9 (de) * 2000-12-22 2009-02-12 Nasalis Pain Relief International Gmbh Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung
DE60209511T2 (de) * 2001-09-18 2006-10-05 Nycomed Danmark Aps Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
EP1450739A4 (en) * 2001-10-12 2008-12-17 Cns Inc NASAL MOISTURIZING GEL AND APPLICATOR
US20050143471A1 (en) * 2001-10-22 2005-06-30 Shen Gao Taste masking spill-resistant formulation
US20030235618A1 (en) * 2001-10-22 2003-12-25 Taro Pharmaceutical Industries Ltd. Taste masking spill-resistant formulation
DE10161110A1 (de) † 2001-12-12 2003-06-26 Ursapharm Arzneimittel Gmbh Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
US20050142208A1 (en) 2002-05-09 2005-06-30 Won Min Yoo Pharmceutical composition for treatment of wounds conntaining blood plasma or serum
DE20318634U1 (de) * 2003-11-13 2004-02-26 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
TWI393567B (zh) * 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法
US10183076B2 (en) * 2005-05-16 2019-01-22 Resdevco Research And Development Co. L Topical compositions for treatment of irritation of mucous membranes
US7323184B2 (en) 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
US8337906B2 (en) * 2006-07-25 2012-12-25 Zinreich James Nasal composition
US20080026078A1 (en) * 2006-07-25 2008-01-31 Zinreich James Nasal composition
US20170202835A1 (en) * 2007-10-31 2017-07-20 Bitop Ag Osmolyte-containing preparation for the treatment of dry mucous membranes
DE102007052380A1 (de) 2007-10-31 2009-05-07 Bitop Ag Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
US20170354624A1 (en) * 2007-11-14 2017-12-14 Resdevco Research And Development Co. Ltd. Topical compositions for treatment of skin irritation
US8173183B2 (en) 2008-07-02 2012-05-08 Carmell Hergert Mucosal membrane healant and moisturizer
DE102008039231A1 (de) 2008-08-22 2010-02-25 Bitop Ag Verwendung von Glucosylglycerol
US20100147300A1 (en) * 2008-12-17 2010-06-17 Clickmist, A Series Of The Invention Machine, Llc Nasal humidification and dispensing device
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
ITUB20156870A1 (it) * 2015-12-11 2017-06-11 Laboratori Baldacci Spa Combinazione sinergica di acido pirrolidoncarbossilico e/o suoi sali o derivati e acido ialuronico e/o suoi sali, per uso nel trattamento e/o prevenzione della secchezza e dell'irritazione delle mucose, e relative formulazioni farmaceutiche.
US20200246311A1 (en) * 2017-08-10 2020-08-06 Elixir Ilac Arastirma Ve Gelistirme A.S. Nasal decongestant compositions comprising dexpanthenol and sodium hyaluronate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK121137C (da) * 1967-02-17 1976-07-05 Pierrel Spa Middel, i det vesentlige avndfrit, til fastholdelse af medikamenter, hud- eller silmhindebehandlingsmidler eller desinfektionsmidler i kontakt med hud eller slimhinder
GB2023000B (en) * 1978-06-17 1982-10-13 Kowa Co Antinflammatory analgesic gelled ointments
JPS59196825A (ja) * 1983-04-21 1984-11-08 Toshiyuki Nakajima 粘膜保護剤
DE3323389A1 (de) * 1983-06-29 1985-01-10 B. Braun Melsungen Ag, 3508 Melsungen Auf schleimhaeute des mundes, der nase und/oder des rachens wirkende arzneimittel auf der basis von heparin und tensiden
IT1169873B (it) * 1983-10-21 1987-06-03 Prodotti Formenti Srl Composizione farmaceutica ad attivita' sistemica anticolinesterasica, agonista-colinergica ed antimuscarinica
JPS6124510A (ja) * 1984-07-11 1986-02-03 Mainichi Komiyunikeeshiyonzu:Kk 乾燥防止用組成物
JPH0735331B2 (ja) * 1986-01-16 1995-04-19 久光製薬株式会社 外用ゲル製剤
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
JPH0729913B2 (ja) * 1987-03-09 1995-04-05 豊秋 米田 水性潤滑組成物
JP2510052B2 (ja) * 1989-10-31 1996-06-26 コロンビア ラボラトリーズ インコーポレイテッド 組織与湿組成物及び方法
US5036095A (en) * 1989-11-14 1991-07-30 Guy Andermann Therapeutic use of DMDM Hydantoin

Also Published As

Publication number Publication date
FI930656A (fi) 1993-08-25
NL9300263A (nl) 1993-09-16
GB9301938D0 (en) 1993-03-17
AU669351B2 (en) 1996-06-06
SE9300581D0 (sv) 1993-02-22
GB2264235B (en) 1996-07-31
FR2687573A1 (fr) 1993-08-27
GB2264235A (en) 1993-08-25
BE1006233A3 (fr) 1994-06-14
CH685099A5 (de) 1995-03-31
IL101056A0 (en) 1992-11-15
DK19893A (da) 1993-08-25
DK19893D0 (da) 1993-02-23
CA2090749A1 (en) 1993-08-25
FR2687573B1 (fr) 1995-04-07
US5376365A (en) 1994-12-27
FI930656A0 (fi) 1993-02-15
AU3375693A (en) 1993-08-26
DE4304893A1 (da) 1993-08-26
SE9300581L (sv) 1993-08-25

Similar Documents

Publication Publication Date Title
IL101056A (en) Composition for nasal treatment
EP0825885A4 (en) PULMONAL ADMINISTRATION OF MEDICINES IN AEROSOL FORM
MX9605650A (es) Formulaciones de propionato de fluticasona.
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
IT1255258B (it) Composizioni farmaceutiche per l'applicazione per via nasale.
DE60210402D1 (de) System zur Abgabe einer Tobramycin-Formulierung
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
CA2277824A1 (en) Dosage composition for nasal delivery and method of use of the same
BG101118A (en) Therapeutical compounds
DE69329400D1 (de) L-Dopa Ester enthaltende Zusammensetzung
CA2289717A1 (en) Novel therapy for constipation
ATE134509T1 (de) Fluorchlorkohlenwasserstoffreie aerosolformulierungen
EE9700132A (et) Inhalatsiooniseade, meetod farmatseutilise toimeaine pihustamiseks ning meetod farmatseutilise toimeaine doosi manustamiseks
IL125534A0 (en) A unit dose of budesonide and use thereof for nasal administration
SE9203743D0 (sv) Efficient use
DE69518334D1 (de) Pharmazeutische aerosol welche mindestens ein zucker enthält
IS4516A (is) Nýtt lyfjaform
ID22763A (id) Komposisi penstabil tibolon
CA2135614A1 (en) Use of urodilatin in pulmonary and bronchial diseases
PL348202A1 (en) Pharmaceutically active composition and dispensing device
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
LT96093A (en) The active ingredient of pharmaceutical composition for treating aphtae and stomatitis
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
YU40398A (sh) Kompozicija nazalnog spreja za davanje sredstva za lečenje odloženog napada emezisa

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees